Singapore, Aug. 15, 2025 (GLOBE NEWSWIRE) -- DEALISM PTE. LTD. announced the launch of DEALISM, the world’s first AI agent purpose-built to transform the daily workflow of individual salespeople for WhatsApp business. Powered by advanced large language model(LLM), deep learning, reasoning model, reinforce learning(RL) and multi-agent, DEALISM acts as a 24/7 intelligent sales partner—handling complex, proactive, multi-turn customer conversations, automating repetitive tasks, and continuously self-learning from each interaction to deliver better outcomes.
Breaking Cover at Monterey Car Week 2025, the Hybrid EREV Gyesera Begins Production in Q4/2025 and is the Long-Awaited Successor to the Innovative Revero
MONTEREY, Calif.,...
With Nintendo Switch 2 Giveaway Just in Time for Back-to-School
HOUSTON, Aug. 15, 2025 /PRNewswire/ -- First Service Credit Union is thrilled to announce the...
MIAMI, Aug. 15, 2025 /PRNewswire/ -- Knowledge-based assessments remain a foundation of medical education. However, leveraging these resources for learning requires detailed and verifiable...
Smithtown, NY, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Post-Traditional Careers, the latest innovation from learning solutions firm Hyphen Innovation, is introducing AI-powered career education and coaching solutions that bring modern, personalized, and scalable approaches to preparing people for the future of work.
DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025...
High-quality program meets ESSA Level 2 Evidence for its positive impact on learning outcomes, showing Florida students using myPerspectives had significant ELA gains and...
DALLAS, Aug. 15, 2025 /PRNewswire/ -- The Taiwan Excellence Pavilion made a dynamic debut at Taiwan Expo USA 2025 in Dallas, showcasing more than 60...
HOLMDEL, N.J., Aug. 15, 2025 /PRNewswire/ -- The New Jersey Digital Marketing Conference (NJDMC) is back on Thursday, October 23, 2025, bringing together the...
IRVING, Texas, Aug. 15, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published...
PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...
Wenge Invests in Cherrypicks to Jointly Drive China's AI Go-Global Strategy and Elevate Hong Kong's AI Ecosystem
HONG KONG, Aug. 15, 2025 /PRNewswire/ -- NetDragon...